首页 / 院系成果 / 成果详情页

Frequency and clinical significance of NF1 mutation in lung adenocarcinomas from East Asian patients  期刊论文  

  • 编号:
    fedff8ed-dbee-41ff-b0cd-18fdb28b3e4e
  • 作者:
  • 语种:
    英文
  • 期刊:
    INTERNATIONAL JOURNAL OF CANCER ISSN:0020-7136 2019 年 144 卷 2 期 (290 - 296) ; JAN 15
  • 收录:
  • 关键词:
  • 摘要:

    NF1 is a tumor suppressor gene that negatively regulates Ras signaling. NF1 deficiency plays an important role in carcinogenesis. To investigate the frequency and clinical significance of NF1 mutation, we examined mutation status of NF1, TP53, LKB1 and RB1 in 704 surgically resected lung adenocarcinomas from East Asian patients using semiconductor-based Ion Torrent sequencing platform. Common driver events, including mutations in EGFR, KRAS, HER2, BRAF, MET, and fusions affecting ALK, RET and ROS1, were also concurrently detected. The correlation between NF1 mutations and clinicomolecular features of patients was further evaluated. Among 704 patients, 42 NF1 mutations were found in 33 patients (33/704, 4.7%), including 14 patients harboring EGFR/NF1 comutations (14/33, 42.4%). Comparing with EGFR-mutant patients, patients harboring NF1 mutations were closely associated with solid component subtype (p = 0.028). Comparing with KRAS mutations, NF1 mutations were found more common in female and never smokers (p = 0.003 and p = 0.004, respectively). Kaplan-Meier survival analysis revealed that patients harboring NF1 mutation had similar disease-free survival (DFS) and overall survival (OS) with patients with KRAS mutation. Although frequently overlapped with EGFR mutation, patients harboring NF1 mutation had significantly shorter DFS (p = 0.019) and OS (p = 0.004) than patients with EGFR mutation. During follow-up, one female patient with EGFR exon 19 deletion and NF1 Q1815X comutation showed poor response to EGFR TKIs (Gefitinib and Osimertinib) after disease relapse. In conclusion, NF1 mutations define a unique molecular and clinicopathologic subtype of lung adenocarcinoma. Examination of NF1 mutation may contribute to molecular subtyping and therapeutic intervention of lung adenocarcinoma.

  • 推荐引用方式
    GB/T 7714:
    Pan Yunjian,Yuan Chongze,Cheng Chao, et al. Frequency and clinical significance of NF1 mutation in lung adenocarcinomas from East Asian patients [J].INTERNATIONAL JOURNAL OF CANCER,2019,144(2):290-296.
  • APA:
    Pan Yunjian,Yuan Chongze,Cheng Chao,Zhang Yiliang,&Chen Haiquan.(2019).Frequency and clinical significance of NF1 mutation in lung adenocarcinomas from East Asian patients .INTERNATIONAL JOURNAL OF CANCER,144(2):290-296.
  • MLA:
    Pan Yunjian, et al. "Frequency and clinical significance of NF1 mutation in lung adenocarcinomas from East Asian patients" .INTERNATIONAL JOURNAL OF CANCER 144,2(2019):290-296.
  • 条目包含文件:
    文件类型:PDF,文件大小:
    正在加载全文
浏览次数:8 下载次数:0
浏览次数:8
下载次数:0
打印次数:0
浏览器支持: Google Chrome   火狐   360浏览器极速模式(8.0+极速模式) 
返回顶部